Tetrahydrobiopterin: a critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction?
- 1 June 2001
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 280 (6) , H2484-H2488
- https://doi.org/10.1152/ajpheart.2001.280.6.h2484
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Oxidation of Tetrahydrobiopterin by Peroxynitrite: Implications for Vascular Endothelial FunctionBiochemical and Biophysical Research Communications, 1999
- Nitric Oxide and the Vascular Endothelium in Myocardial Ischemia-Reperfusion InjuryaAnnals of the New York Academy of Sciences, 1999
- Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.Journal of Clinical Investigation, 1997
- Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1996
- Hypercholesterolemia increases endothelial superoxide anion production.Journal of Clinical Investigation, 1993
- Regulation of the L‐arginine‐dependent and tetrahydrobiopterin‐dependent biosynthesis of nitric oxide in murine macrophagesEuropean Journal of Biochemistry, 1993
- Macrophage nitric oxide synthase: relationship between enzyme-bound tetrahydrobiopterin and synthase activityBiochemistry, 1992
- Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginineThe Lancet, 1991
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980